Skip to main content
Sale!

Survodutide

Metabolic / GLP-1 Research

$77.99 $122.99Price range: $77.99 through $122.99

15 people viewed this in the last 24 hours

Survodutide – an investigational dual glucagon/GLP-1 receptor agonist studied for metabolic, weight and liver research. Choose 5mg or 10mg.

Specifications

FormLyophilized powder
Purity>99% (third-party lab tested)
Typical dose2 mg weekly (reference)
Reconstitute2 mL bacteriostatic water
ApplicationLaboratory research use only

Reconstitution calculator

Work out concentration, draw volume, and doses per vial. For laboratory research planning only.

ml
, Concentration (mg/ml)
, Draw to this line (IU on a U-100 syringe)
, Doses per vial

How to read it: on a standard U-100 insulin syringe, 100 IU = 1 ml. The middle figure is the line to draw to. Always confirm against the research protocol. Products are sold for laboratory research use only, not for human consumption.

SKU: N/A Categories: ,

Description

Survodutide is an investigational dual glucagon/GLP-1 receptor agonist studied for metabolic, weight-reduction and liver-related research - adding glucagon-receptor action to the incretin pathway. Available in 5mg and 10mg.

Why it stands out

  • Dual agonism: glucagon receptor + GLP-1 receptor in research models
  • Studied for body-weight and glucose-handling endpoints
  • Glucagon arm studied for energy expenditure and hepatic lipid metabolism
  • Select your dosage below - 5mg or 10mg, third-party tested to >99% purity

Supplied as lyophilised powder, >99% purity, third-party lab-tested with a certificate of analysis on every batch. For laboratory and research use only — not for human or animal consumption.

Categories: ,

Reviews

There are no reviews yet.

Be the first to review “Survodutide”

Your email address will not be published. Required fields are marked *

Currency
USD United States (US) dollar
THB Thai baht
Survodutide COA on every batch · Card or crypto (USDC & USDT) 10 bought today
0 items in your cart 0 items in your cart$0.00 Checkout →